GSDMA and neoplasm: In this work, to leverage Gasdermin-triggered pyroptosis for antitumor immunotherapy, we develop an intracellular bacterium—attenuated Salmonella typhimurium (VNP) delivery system to shuttle Gasdermin D protein to initiate the tumor cell pyroptosis.